Transcat (NASDAQ: TRNS) is one of 61 public companies in the “MISC TECHNOLOGY” industry, but how does it contrast to its peers? We will compare Transcat to related businesses based on the strength of its analyst recommendations, dividends, profitability, institutional ownership, risk, valuation and earnings.
Earnings and Valuation
This table compares Transcat and its peers gross revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Transcat||$143.90 million||$4.52 million||23.01|
|Transcat Competitors||$1.91 billion||$346.77 million||44.25|
Transcat’s peers have higher revenue and earnings than Transcat. Transcat is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
Volatility and Risk
Transcat has a beta of 0.39, indicating that its share price is 61% less volatile than the S&P 500. Comparatively, Transcat’s peers have a beta of 0.87, indicating that their average share price is 13% less volatile than the S&P 500.
This table compares Transcat and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
This is a breakdown of current ratings and target prices for Transcat and its peers, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Transcat presently has a consensus target price of $20.00, indicating a potential upside of 27.80%. As a group, “MISC TECHNOLOGY” companies have a potential upside of 1.99%. Given Transcat’s stronger consensus rating and higher probable upside, analysts plainly believe Transcat is more favorable than its peers.
Institutional & Insider Ownership
55.2% of Transcat shares are held by institutional investors. Comparatively, 63.9% of shares of all “MISC TECHNOLOGY” companies are held by institutional investors. 8.8% of Transcat shares are held by company insiders. Comparatively, 10.2% of shares of all “MISC TECHNOLOGY” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Transcat peers beat Transcat on 7 of the 13 factors compared.
Transcat, Inc. is a provider of calibration and laboratory instrument services and a distributor of professional grade test, measurement and control instrumentation. The Company conducts its business through two segments: service (Service) and distribution (Distribution). Through the Service segment, the Company offers calibration, repair, inspection, analytical qualifications, preventative maintenance and other related services, a majority of which are processed through its asset management system, CalTrak (CalTrak). Through its Distribution segment, the Company markets, sells and rents national brand instruments to customers around the globe. The Company is focused on providing its services and products to the life science industries, which include pharmaceutical, biotechnology, medical device manufacturing and other Food and Drug Administration (FDA)-regulated businesses.
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.